Mycosis fungoides: Disease evolution and prognosis of 309 Dutch patients

Archives of Dermatology

Volumn 136, Issue 4, 2000, Pages 504-510

  Van Doorn, Remco ^a   Van Haselen, Christian W ^c   Van Voorst Vader, Pieter C ^d   Geerts, Marie Louise ^h   Heule, Freerk ^e   De Rie, Menno ^b   Steijlen, Peter M ^f   Dekker, Sybren K ^g   Van Vloten, Willem A ^c   Willemze, Rein ^a,g  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^g LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MYCOSIS FUNGOIDES; NETHERLANDS; PRIORITY JOURNAL; PROGNOSIS; SKIN LYMPHOMA; T CELL LYMPHOMA;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM STAGING; NETHERLANDS; PROGNOSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SKIN; SKIN NEOPLASMS;

EID: 0343341222     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Weinstock M, Horm J. Mycosis fungoides in the United States: increasing incidence and descriptive epidemiology. JAMA. 1988;260:42-46.
2. Weinstock M, Horm J. Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoides. Cancer. 1988;62:1658-1661.
3. Lamberg S, Green S, Byar D, et al. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group. Cancer Treat Rep. 1979; 63:701-707.
4. Hamminga L, Hermans J, Noordijk E, Meijer C, Scheffer E, van Vloten W Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients. Br J Dermatol. 1982;107:145-155.
5. Sausville E, Eddy J, Makuch R, et al. Histopathological staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups. Ann Intern Med. 1988;109:372-382.
6. Hoppe R, Wood G, Abel E. Mycosis fungoides and the Sézary syndrome: pathology, staging and treatment. Curr Probl Cancer. 1990;14:293-371.
7. Hermann J, Roenigk H, Hurria A, et al. Treatment of mycosis fungoides with photochemotherapy (PUVA): long-term follow-up. J Am Acad Dermatol. 1995; 33:234-242.
8. Zackheim H. Topical carmustine (BCNU) for patch/plaque mycosis fungoides. Semin Dermatol. 1994;13:202-206.
9. Quiros P, Kacinski B, Wilson L. Extent of skin involvement as a prognostic indicator of disease tree survival and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy. Cancer. 1996;77:1912-1917.
10. Kim Y, Jensen R, Watanabe G, Varghese A, Hoppe R. Clinical stage IA (limited patch and plaque) mycosis fungoides. Arch Dermatol. 1996;132:1309-1313.
11. Toro J, Stoll H, Stomper P, Oseroff A. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. J Am Acad Dermatol. 1997;37:58-67.
12. Vonderheid E, Ekbote S, Kerrigan K, et al. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma. J Invest Dermatol. 1998;110:946-950.
13. Kim Y, Chow S, Varghese A, Hoppe R. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch Dermatol. 1999;135:26-32.
14. Zackheim H, Amin S, Kashani-Sabet M, McMillan A. Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients, J Am Acad Dermatol. 1999;40:418-425.
15. Beljaards R, Meijer C, Scheffer E, et al. Prognostic significance of CD30 (Ki-1/ Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin: a clinico-pathological and histochemical study in 20 patients. Am J Pathol. 1989; 135:1169-1178.
16. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group ot the European Organization for Research and Treatment of Cancer. Blood. 1997;90: 354-371.
17. Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque stage mycosis fungoides. Am J Dermatopathol. 1988;10:469-477.
18. Fuks Z, Bagshaw M, Farber E. Prognostic signs and the management of the mycosis fungoides. Cancer. 1973;32:1385-1395.
19. Bunn P, Lamberg S. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep. 1979;63:725-728.
20. Scheffer E, Meijer C, Van Vloten W. Dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Cancer. 1980;45:137-148.
21. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:475-480.
22. Cox D, Snell E. Analysis of Binary Data. New York, NY: Chapman & Hall; 1989.
23. Beljaards R, Willemze R. The prognosis of patients with lymphomatoid papulosis associated with other types of malignancies. Br J Dermatol. 1992;126:596-602.
24. Basarab T, Fraser-Andrews E, Orchard G, et al. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br J Dermatol. 1998;139: 630-638.
25. Wilson L, Cooper D, Goodrich A, et al. Impact of non-CTL dermatologic diagnosis on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys. 1994;28:829-837.
26. King-Ismael D, Ackerman AB. Guttate parapsoriasis/digitate dermatosis (small plaque parapsoriasis) is mycosis fungoides. Am J Dermatopathol. 1992;14:518-530.
27. Weiss LM, Hu E, Wood GS, et al. Clonal rearrangements of T-cell receptor genes in mycosis fungoides and dermatopathic lymphadenopathy. N Eng J Med. 1985; 313:539-544.
28. Bakels V, van Oostveen JW, Geerts ML, et al. Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides. J Pathol. 1993;170:249-255.